References
1.
Franklin WA, Pulford K, Falini B: Immunocytochemical analysis of human mononuclear phagocytes using monoclonal antibodies. Lab Invest 1986;54:332–335.
2.
Athanasou NA, Heryet A, Quinn J, Gatter KC, Mason DY, McGee JO: Osteoclasts contain macrophage and megakaryocyte antigens. J Pathol 1986;150:239–246.
3.
Kelly PMA, Bliss E, Morton JJA, Burns J, McGee JO: Monoclonal antibody EBM11: High cellular specificity for human macrophages. J Clin Pathol 1988;41:510–515.
4.
Davey FR, Erber WN, Gatter KC, Mason DY: Immunophenotyping of acute myeloid leukemia by immunoalkaline phosphatase (APAAP) labelling with a panel of antibodies. Am J Hematol 1987;26:157–166.
5.
Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter J, Feliu E, Cervantes F, Vives-Corrons J, Monteserrat E, Rozman C: The value of detecting surface and cytoplasmic antigens in acute myeloid leukemia. Br J Haematol 1992;81:1778–1785.
6.
Warnke RA, Pulford KAF, Pallesen G, Ralfkiaer E, Brown DC, Gatter KC, Mason DY: Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol 1989;135:1089–1095.
7.
Kurec AS, Cruz VE, Barret D, Mason DY, Davey FR: Immunophenotyping of acute leukemias using paraffin embedded tissue sections. Am J Clin Pathol 1990;93:502–509.
8.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Co-Operative Group. Ann Intern Med 1985;103:620–625.
9.
Bennett JM, Catovsky D, Daniel M, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). Ann Intern Med 1985;103:460–462.
10.
Moir DJ, Ghosh AK, Abdulaziz Z, Knight PM, Mason DY: Immunoenzymatic staining of haematological samples with monoclonal antibodies. Br J Haematol 1983;55:395–410.
11.
Gloghini A, Cozzi M, Sulfaro S, Volpe R, Carbone A: A combined cytochemical and immunocytochemical method for simultaneous visualisation of cytoplasmic enzyme reactivity and cell surface antigens in cell suspensions. Am J Clin Pathol 1989;91:67–71.
12.
Strobl H, Scheinecker C, Csmarits B, Majdic O, Knapp W: Flow-cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol 1995;90:774–782.
13.
Shome DK, Gupta NK, Prajapati NC, Raju GMK, Choudhury P, Dubey AP: Orbital granulocytic sarcomas (myeloid sarcomas) in acute nonlymphocytic leukemia. Cancer 1992;70:2298–2301.
14.
Pulford KA, Sipos A, Cordell JL, Stross WP, Mason DY: Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 1990;2:973–980.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
